The hunger hormone ghrelin has multiple cardioprotective effects — lowering blood pressure, preventing arrhythmias, reducing heart failure, and limiting damage after heart attacks — through anti-inflammatory and anti-cell-death mechanisms.
Multiple cardioprotective effectsGhrelin protects the heart through at least five distinct mechanisms: anti-inflammation, anti-apoptosis, sympatholytic activity, autophagy regulation, and endothelial repair
What the researchers found
Ghrelin, a 28-amino-acid peptide from the stomach, has multiple cardioprotective effects beyond its well-known role in appetite and growth hormone. Research shows ghrelin modulates sympathetic nervous system activity and blood pressure, enhances blood vessel function and new vessel growth (angiogenesis), inhibits cardiac arrhythmias, reduces heart failure progression, and inhibits harmful cardiac remodeling after heart attacks.
The underlying mechanisms include anti-inflammatory effects, prevention of cell death (anti-apoptosis), suppression of sympathetic nerve overactivation, regulation of autophagy, and correction of endothelial dysfunction. However, the molecular details remain incompletely understood and no ghrelin-based cardiovascular drug exists yet.
Why it matters
Heart disease remains the leading cause of death globally, and the discovery that a stomach peptide protects the heart opens unexpected therapeutic avenues. Ghrelin's broad cardioprotective profile — spanning blood pressure, arrhythmias, heart failure, and post-heart-attack remodeling — suggests it targets fundamental cardiovascular processes. Developing ghrelin pathway drugs could provide new treatments for conditions where current options are limited.
The numbers in context
28-amino-acid peptide · Identified 1999 · Receptor: GHS-R1a · Cardioprotective effects: anti-hypertensive, anti-arrhythmic, anti-remodeling, pro-angiogenic · Mechanisms: anti-inflammatory, anti-apoptotic, sympatholytic
How the study worked
Narrative review of published research on ghrelin's cardiovascular effects, covering studies on hypertension, vascular function, arrhythmias, heart failure, and post-myocardial infarction remodeling. Discusses proposed molecular mechanisms including inflammatory, apoptotic, autophagy, and endothelial pathways.
Who was studied
Not applicable (narrative review of preclinical and clinical ghrelin cardiovascular research)
What this study cannot tell us
Narrative review — not a systematic review or meta-analysis. Most cardiovascular ghrelin research is preclinical (cell and animal studies); human clinical data is limited. No ghrelin-based cardiovascular therapy has reached clinical trials. The multiple proposed mechanisms suggest the field is still early and the exact therapeutic targets remain unclear.
How to read the evidence
This is a narrative review synthesizing primarily preclinical research. While the breadth of evidence is extensive, most studies are in animal models. Clinical data on ghrelin's cardiovascular effects in humans remains limited.
When this study was published
Published in 2021, this review covers ghrelin cardiovascular research through that time. The field continues to develop, though clinical translation remains elusive.
The bigger picture
Ghrelin's cardiovascular effects reveal how gut-derived peptides influence organs far beyond the digestive system. This 'gut-heart axis' is part of a broader recognition that peptide hormones have systemic roles. As growth hormone secretagogues (like MK-677 and ipamorelin) gain attention in wellness communities, understanding ghrelin's cardiovascular implications becomes clinically relevant — both for potential benefits and safety monitoring.
Questions still open
- Could ghrelin receptor agonists be developed as cardiovascular drugs for heart failure or post-heart-attack recovery?
- Do people using growth hormone secretagogues that activate ghrelin pathways experience cardiovascular benefits?
- Why hasn't ghrelin's cardiovascular potential translated into clinical drug development despite decades of promising data?
Common questions
How does a hunger hormone protect the heart?
Do growth hormone peptides like MK-677 have heart benefits?
Read the original research
Research progress of ghrelin on cardiovascular disease.
Bioscience reports, 41(1)
Citation
Yuan, Ming-Jie; Li, Wei; Zhong, Peng. (2021). Research progress of ghrelin on cardiovascular disease.. Bioscience reports, 41(1). https://doi.org/10.1042/BSR20203387